Sensitivity in detecting osseous lesions depends on anatomic localization: planar bone scintigraphy versus 18F PET.
暂无分享,去创建一个
J Kotzerke | G Glatting | H. Schirrmeister | G. Glatting | K. Nuessle | S. Reske | A. Guhlmann | M. Rentschler | B. Neumaier | J. Kotzerke | K Elsner | H Schirrmeister | S N Reske | A Guhlmann | K. Elsner | M Rentschler | B Neumaier | H Träger | K Nüssle | H. Träger | Mary Rentschler | Harald Trager | Naumann Karin
[1] Robert H. Martin,et al. Role of SPECT in differentiating malignant from benign lesions in the lower thoracic and lumbar vertebrae. , 1993, Radiology.
[2] B F Boyce,et al. Bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice. , 1995, Cancer research.
[3] J. Barrio,et al. Evaluation of the skeletal kinetics of fluorine-18-fluoride ion with PET. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[4] R. Rubens,et al. The clinical course of bone metastases from breast cancer. , 1987, British Journal of Cancer.
[5] K. Pantel,et al. Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastases , 1996, The Lancet.
[6] J. Hanley,et al. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. , 1983, Radiology.
[7] J A Frank,et al. Detection of malignant bone tumors: MR imaging vs scintigraphy. , 1990, AJR. American journal of roentgenology.
[8] S. Reske,et al. RADIOIMMUNOIMAGING FOR DIAGNOSIS OF BONE MARROW INVOLVEMENT IN BREAST CANCER AND MALIGNANT LYMPHOMA , 1989, The Lancet.
[9] Z. Traill,et al. Magnetic resonance imaging of metastatic bone disease. , 1995, Clinical orthopaedics and related research.
[10] S. Noguchi,et al. Results of surgical treatment for sternal metastasis of breast cancer , 1988, Cancer.
[11] P. Hoskin,et al. Radiotherapy for painful bone metastases , 1994, Palliative medicine.
[12] M. Timins,et al. Diagnostic bone scanning in oncology. , 1997, Seminars in nuclear medicine.
[13] J. Hermans,et al. REDUCED MORBIDITY FROM SKELETAL METASTASES IN BREAST CANCER PATIENTS DURING LONG-TERM BISPHOSPHONATE (APD) TREATMENT , 1987, The Lancet.
[14] A. Greenspan,et al. Negative Bone Scintigraphy With Diffuse Osteoblastic Breast Carcinoma Metastases , 1994, Clinical nuclear medicine.
[15] R. Tadmor,et al. Early MR Demonstration of Spinal Metastases in Patients with Normal Radiographs and CT and Radionuclide Bone Scans , 1989, Journal of computer assisted tomography.
[16] E. Eisenhuber,et al. Differential diagnosis of atypically located single or double hot spots in whole bone scanning. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.